Search This Blog

Tuesday 1 November 2022

In News

In News


Larsen & Toubro: L&T consolidated PAT grows 22.5 percent to Rs 2,229 crore as consolidated revenue grows 23 percent to Rs 42,763 crore driven by execution tailwinds in the infrastructure projects segment and sustained growth momentum in the IT & TS portfolio. The company won orders worth Rs 51,914 crore at the group level during the quarter, a YoY growth of 23 percent. The consolidated order book of the group was at Rs 372,381 crore as of September-end.


Tata Steel: The company reported an 87 percent YoY decline in consolidated PAT at Rs 1,514 crore as revenue remained flat at Rs 59,878 crore. Concerns about a slowdown in key economies, persisting geopolitical issues coupled with seasonal factors led to a volatile operating environment. Sequentially, the profit declined by 80 percent. The production for the quarter was down 3 percent on-year and deliveries were down 2 percent. EBITDA per ton tanked 60 percent on year and QoQ to Rs 8,673 crore.


Castrol India: The lubricants company reported a flat growth in its PAT of Rs 187 crore while the revenues rose 4 percent to Rs 1,121 crore. The performance was impacted by forex pressures and inflationary pressures, leading to rising costs of additives and base oil.


Glenmark Pharmaceuticals: Glenmark Pharmaceuticals Inc (USA) launched Fingolimod capsules, 0.5 mg, the generic version of Gilenya1 Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation. According to IQVIA sales data for the 12-month period ending September 2022, the Gilenya Capsules, 0.5 mg market achieved annual sales of approximately $1.8 billion.


Data Patterns: Data Patterns reported a growth of 63 percent in PAT to Rs 21 crore aided by the decline in operating costs. The total revenue grew 51 percent to Rs 90 crore. The company has Rs 884 crore worth of orders in hand.


GHCL: The company announced a 212 percent on-year growth in its net profit to Rs 289 crore as compared to Rs 93 crore a year ago. The standalone revenue was up 73 percent to Rs 1,389 crore and was aided by the doubling of its inorganic chemicals business, the revenue for which grew by 98 percent on-year to Rs 1,130 crore. EBITDA was up 159 percent on-year to Rs 442 crore.


Equitas Small Finance Bank: The small finance bank recorded a profit of Rs 116 crore for the quarter ended September FY23, increasing 183 percent YoY. Net interest income for Q2FY23 at Rs 610 crore increased by 26 percent YoY. Gross advances at Rs 22,779 crore as of September FY23 grew by 20 percent YoY and disbursement at Rs 3,845 crore increased 22 percent YoY.

No comments:

Post a Comment

SLL -- Short Term

SHORT TERM CALL Buy Suven Life Sciences Cmp 63 SL Below 55 Tgt 66 / 69 / 72 / 75 / 78++ In Coming Days..